| Summary |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Medicine > Price May Stop Merk’s New Diabetes Drug From Helping Victims |
|
Summary - Price May Stop Merk’s New Diabetes Drug From Helping Victims
On October 17, 2006, Merk released its new drug to fight type 2 diabetes. The FDA approval of the new drug wi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ll potentially help over 20 million people who suffer from type 2 diabetes. The new oral medication Januvia c ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ontrols blood sugar levels just as well as the other diabetes medication on the market but with fewer side eff lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ects. The new drug increases the level of a hormone that makes the pancreas produce higher levels of insulin here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe in order to process more blood sugar, while at the same telling the liver to stop the production of glucose. d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro anuvia does this by blocking the production of the enzyme DPP-4. Although the drug is just as affective as ot ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc her diabetes drugs on the market just with drastically reduced side affects, the downside is that Merk is goin easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi g to charge from 6 to 12 times more than other similar drugs already on the market. This will increase the da nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ily price for diabetes medication for a user from $.50 a day to $6.00.A drug that has the potential to positiv and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ely affect the lives of the estimated 230 million people worldwide that suffer from this disease may never get ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi to reach many of those consumers to the drastically high prices. This is a great example of how big pharmaceu ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a tical companies can charge whatever they want for their new innovative drugs. America does not have price con dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod trols in order to promote the production of new innovative drugs, but what good does the new innovative drug d cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin o us if no one can afford it. Where do the people who can’t afford insurance turn to? What’s the best altern tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ative to paying the outrageous prices? If you are in need of a reasonable price on your online medication try t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel looking for your medication online from sources such as Canada. Canada offers the exact same medication that ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust we sell on our shelves but at substantially lower prices. Websites like FreebeeForiegnPharmacy.com will help y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products you locate the cheapest prescription medication from Canadian and other foreign pharmacies at a fraction of th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e cost that you would pay at your local American pharmacy. Freebee also lists all consumer feedback left abou elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip t its pharmacies by its members assuring you that you order from only the safest and most reputable pharmacies tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Surefire Way To Make Money With Google Adsense... Each And Every Month! Any Pain Or Discomfort That Just Won't Go Away Even With Surgery?
|